|
1
|
Chen HK, Liu XQ, Lin J, Chen TY, Feng QS
and Zeng YX: Mutation analysis of KLF6 gene in human nasopharyngeal
carcinomas. Ai Zheng. 21:1047–1050. 2002.(In Chinese). PubMed/NCBI
|
|
2
|
Lo KW and Huang DP: Genetic and epigenetic
changes in nasopharyngeal carcinoma. Semin Cancer Biol. 12:451–462.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW,
Tsang YS, Wong N, Whitney BM and Lee JC: Nasopharyngeal carcinoma
cell line (C666-1) consistently harbouring Epstein-Barr virus. Int
J Cancer. 83:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim VN and Nam JW: Genomics of microRNA.
Trends Genet. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olena AF and Patton JG: Genomic
organization of microRNAs. J Cell Physiol. 222:540–545.
2010.PubMed/NCBI
|
|
9
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong W, He B, Zhu C, Xiao L, Zhou S and
Peng X: MiR-143 inhibits migration of human nasopharyngeal
carcinoma cells by negatively regulating GLI3 gene. Nan Fang Yi Ke
Da Xue Xue Bao. 33:1057–1061. 2013.(In Chinese). PubMed/NCBI
|
|
12
|
Peng X, Guo W, Liu T, Wang X, Tu X, Xiong
D, Chen S, Lai Y, Du H, Chen G, et al: Identification of miRs-143
and −145 that is associated with bone metastasis of prostate cancer
and involved in the regulation of EMT. PLoS One. 6:e203412011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B,
Gu J, Chen HY and Sun XF: Clinicopathological significance of
microRNA-31, −143 and −145 expression in colorectal cancer. Dis
Markers. 26:27–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
−145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Noguchi S, Mori T, Hoshino Y, Maruo K,
Yamada N, Kitade Y, Naoe T and Akao Y: MicroRNA-143 functions as a
tumor suppressor in human bladder cancer T24 cells. Cancer Lett.
307:211–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Medema RH, Kops GJ, Bos JL and Burgering
BM: AFX-like Forkhead transcription factors mediate cell-cycle
regulation by Ras and PKB through p27kip1. Nature. 404:782–787.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kozar K and Sicinski P: Cell cycle
progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell
Cycle. 4:388–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Wu J, Lin Y, Zhu Y, Xu X, Xu X,
Liang Z, Li S, Hu Z, Zheng X and Xie L: MicroRNA-320c inhibits
tumorous behaviors of bladder cancer by targeting Cyclin-dependent
kinase 6. J Exp Clin Cancer Res. 33:692014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Wang L, Li B, Huo M, Mu M, Liu J
and Han J: miR-145 downregulates the expression of cyclin-dependent
kinase 6 in human cervical carcinoma cells. Exp Ther Med.
8:591–594. 2014.PubMed/NCBI
|
|
22
|
Kikkawa N, Kinoshita T, Nohata N, Hanazawa
T, Yamamoto N, Fukumoto I, Chiyomaru T, Enokida H, Nakagawa M,
Okamoto Y and Seki N: microRNA-504 inhibits cancer cell
proliferation via targeting CDK6 in hypopharyngeal squamous cell
carcinoma. Int J Oncol. 44:2085–2092. 2014.PubMed/NCBI
|
|
23
|
Honeywell DR, Cabrita MA, Zhao H,
Dimitroulakos J and Addison CL: miR-105 inhibits prostate tumour
growth by suppressing CDK6 levels. PLoS One. 8:e705152013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu YF, Li YQ, Guo R, He QM, Ren XY, Tang
XR, Jia WH, Kang TB, Zeng MS, Sun Y, et al: Identification of
miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on
microRNA expression profiling. Int J Biochem Cell Biol. 61:120–128.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Wu S, Shi Y, Miao Y, Luo X, Ji M,
Yao K and He J: c-MYB regulates cell growth and DNA damage repair
through modulating MiR-143. FEBS Lett. 589:555–564. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choudhury AR, Ju Z, Djojosubroto MW,
Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang
C, Buer J, et al: Cdkn1a deletion improves stem cell function and
lifespan of mice with dysfunctional telomeres without accelerating
cancer formation. Nat Genet. 39:99–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fasano CA, Dimos JT, Ivanova NB, Lowry N,
Lemischka IR and Temple S: shRNA knockdown of Bmi-1 reveals a
critical role for p21-Rb pathway in NSC self-renewal during
development. Cell Stem Cell. 1:87–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
